The Pilot Study of Medical Device-Neuclare for Patients With Idiopathic Normal Pressure Hydrocephalus (iNPH)

Inclusion Criteria

• •Adults aged 60 to 90, regardless of gender
• •Individuals exhibiting gait disturbances along with at least one of the following symptoms: cognitive impairment or urinary incontinence
• •Evans' index \> 0.3)
• •When the symptoms in 2) and 3) cannot be fully explained by other neurological or non-neurological diseases
• •Diagnosis of INPH based on the Investigator's clinical judgement based on criteria as described in the INPH Guidelines
• •A person with a severe history of cancer/tuberculosis
• •A person who has contact dermatitis or sensitive skin abnormalities
• •Patients with a high fever of 40 degrees Celsius or higher based on eardrum body temperature
• •A person whose bleeding is identified due to a common procedure or surgery that may affect vital signs
• •A person who is unable to perform MRI tests
• •A person with an allergic reaction to MRI contrast agents such as Definity or Gadovist.
• •Other cases where the investigator judged that it is difficult to participate in the study
• •Patient with behavioral and psychological symptoms of dementia (BPSD) that make cooperation in the clinical trial difficult
• •Patients with severe cognitive impairment, defined as an MMSE score of 17 or below
• •Patients who have undergone shunt surgery in the past year
• •Patients with a history of uncontrolled thyroid, liver, or kidney dysfunction
• •Patients taking medications that affect gait, cognition, or urinary tract function and who have had a change in medication regimen within the past 3 months.
• •Patients who have undergone a cerebrospinal fluid drainage test within the past 1 month.